Bulk RNA expression analysis showed that PD-L1-negative tumors exhibited an expression profile consistent with abundant cancer-associated fibroblast infiltration, increased matrix stiffness, and impaired immune activation-features consistent with tumor progression and poorer clinical outcomes. The gene discussed is CD274; the disease is neoplasm.